Surveillance and safety.
Eriksson
L I
LI
Leander
E
E
Lennmarken
C
C
D001279:Atracurium / Q000009:adverse effects; D003257:Consumer Product Safety; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D012306:Risk
D009466:Neuromuscular Blocking Agents; D001279:Atracurium